The Goldman Sachs Group, Inc., established in 1869, is a global leader in investment banking, securities, and investment management. It operates in four primary segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Management. The company provides a wide range of services, including financial advisory services for mergers and acquisitions, underwriting services for various securities, client execution services for fixed income, currencies, commodities, and equities, securities services, and wealth advisory services. It serves a diverse client base comprising corporations, financial institutions, governments, and high-net-worth individuals. Additionally, Goldman Sachs invests in a broad array of asset classes, including debt securities, equity securities, real estate, and private equity, demonstrating its commitment to driving growth and innovation across industries.
Managing Director, Asia Pacific Healthcare and Life Sciences Investing
Kaixun Zhang
Managing Director
Teresa Mattamouros
Managing Director, Asset and Wealth Management (Infrastructure Fund)
Tanner Mahoney
Vice President
Ben Fife
Vice President - GS Growth
Past deals in Nanotechnology
Attovia Therapeutics
Series C in 2025
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.
Attovia Therapeutics
Series B in 2024
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.
Impact Nano
Venture Round in 2023
Impact Nano is a manufacturer specializing in advanced materials for the semiconductor industry, focusing on specialty chemicals that enhance various applications. The company utilizes green chemistry and circular manufacturing practices to address global challenges in computing, energy transition, and health. With expertise in ligand, organometallic, silicon, and fluorine chemistry, Impact Nano produces controlled fingerprint chemicals designed for safety, transparency, and sustainability. Their commitment to innovation and excellence enables them to scale up leading technologies and bring them to market effectively. Guided by values of respect for people and the environment, integrity, and an innovative approach, Impact Nano is dedicated to contributing positively to the industries it serves.
MoMa Therapeutics
Series B in 2022
MOMA Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2019. The company focuses on discovering precision medicines by targeting molecular machines that are fundamental to human disease. MOMA Therapeutics utilizes a unique platform that leverages the common features of the ATPase target class, which includes significant conformational changes and energy-driven mechanics. By combining these insights with advancements in structural biology and small-molecule drug discovery, MOMA Therapeutics aims to develop drugs targeting previously challenging enzymes, contributing to the next generation of targeted therapies. The company was formerly known as ATPases NewCo, Inc. before rebranding in March 2020.
Advanced Micro-Fabrication Equipment
Series D in 2010
Advanced Micro-Fabrication Equipment Inc. is a Chinese company that specializes in manufacturing micro-fabrication equipment for the semiconductor industry and high-tech sectors. Founded in 2004 and headquartered in Shanghai, the company is a key supplier of essential equipment used in the production of micron-sized and nanoscale devices. Its product offerings include plasma etching equipment, deep silicon etching equipment, and metal-organic chemical vapor deposition systems. These technologies play a critical role in the development of advanced integrated circuits and LED chips, which are foundational for innovations in artificial intelligence, machine learning, and robotics. Advanced Micro-Fabrication Equipment Inc. serves a growing customer base across China and Asia, contributing to advancements in the semiconductor manufacturing landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.